☰

James B. Wechuck, Ph.D. - Publications

Affiliations: 
2002 University of Pittsburgh, Pittsburgh, PA, United States 
Area:
Chemical Engineering, Biomedical Engineering, Cell Biology
Tree Info Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Goss JR, Krisky D, Bouch K, O'Malley M, Coghlan S, Wechuck J. 184. PGN-503, a Herpes Simplex Virus Based Vector Expressing Neurotrophin-3, Prevents and Reverses Neuropathy in a Mouse Model of Paclitaxel-Induced Peripheral Neuropathy Molecular Therapy. 24. DOI: 10.1016/S1525-0016(16)32993-8  0.364
2014 Goss JR, Krisky D, Wechuck J, Wolfe D. Herpes simplex virus-based nerve targeting gene therapy in pain management. Journal of Pain Research. 7: 71-9. PMID 24470772 DOI: 10.2147/Jpr.S36619  0.434
2014 Okada H, Wolfe D, Wechuck J, Goss JR, Majima T, Chermansky CJ, Yoshimura N. PD9-07 HERPES SIMPLEX VIRUS TYPE-1 (HSV-1) VECTOR-MEDIATED GENE THERAPY OF ENDOMORPHIN FOR BLADDER OVERACTIVITY AND NOCICEPTION Journal of Urology. 191. DOI: 10.1016/J.Juro.2014.02.789  0.52
2011 Goins WF, Krisky DM, Wechuck JB, Wolfe D, Huang S, Glorioso JC. Generation of replication-competent and -defective HSV vectors. Cold Spring Harbor Protocols. 2011: pdb.prot5615. PMID 21536761 DOI: 10.1101/Pdb.Prot5615  0.627
2009 Wolfe D, Wechuck J, Krisky D, Mata M, Fink DJ. A clinical trial of gene therapy for chronic pain. Pain Medicine (Malden, Mass.). 10: 1325-30. PMID 19818042 DOI: 10.1111/J.1526-4637.2009.00720.X  0.368
2009 Kato R, Wolfe D, Coyle CH, Wechuck JB, Tyagi P, Tsukamoto T, Nelson JB, Glorioso JC, Chancellor MB, Yoshimura N. Herpes simplex virus vector-mediated delivery of neurturin rescues erectile dysfunction of cavernous nerve injury. Gene Therapy. 16: 26-33. PMID 18668142 DOI: 10.1038/Gt.2008.132  0.426
2009 KATO R, BENNETT NE, KIM JH, WOLFE D, COYLE CH, HUANG S, WECHUCK JB, GOINS WF, DE MIGUEL F, TSUKAMOTO T, NELSON JB, GLORIOSO JC, CHANCELLOR MB, YOSHIMURA N. Gene Therapy for Neurogenic Erectile Dysfunction Luts: Lower Urinary Tract Symptoms. 1: S44-S47. DOI: 10.1111/J.1757-5672.2009.00045.X  0.439
2008 Craft AM, Krisky DM, Wechuck JB, Lobenhofer EK, Jiang Y, Wolfe DP, Glorioso JC. Herpes simplex virus-mediated expression of Pax3 and MyoD in embryoid bodies results in lineage-Related alterations in gene expression profiles. Stem Cells (Dayton, Ohio). 26: 3119-29. PMID 18787207 DOI: 10.1634/Stemcells.2008-0417  0.534
2008 Goins WF, Krisky DM, Wechuck JB, Huang S, Glorioso JC. Construction and production of recombinant herpes simplex virus vectors. Methods in Molecular Biology (Clifton, N.J.). 433: 97-113. PMID 18679619 DOI: 10.1007/978-1-59745-237-3_6  0.673
2007 Kato R, Wolfe D, Coyle CH, Huang S, Wechuck JB, Goins WF, Krisky DM, Tsukamoto T, Nelson JB, Glorioso JC, Chancellor MB, Yoshimura N. Herpes simplex virus vector-mediated delivery of glial cell line-derived neurotrophic factor rescues erectile dysfunction following cavernous nerve injury. Gene Therapy. 14: 1344-52. PMID 17611585 DOI: 10.1038/Sj.Gt.3302990  0.423
2007 Kato R, Wolfe DP, Coyle CH, Wechuck JB, de Miguel F, Tsukamoto T, Nelson JB, Chancellor MB, Glorioso JC, Yoshimura N. 673: Herpes Simplex Virus Vector-Mediated Delivery of a Penile Neurotrophic Factor, Neurturin, Rescues Erectile Dysfunction Following Cavernous Nerve Injury Journal of Urology. 177: 226-226. DOI: 10.1016/S0022-5347(18)30913-3  0.456
2007 Kato R, Wolfe DP, Coyle CH, Huang S, Wechuck JB, Goins WF, de Miguel F, Tsukamoto T, Nelson JB, Chancellor MB, Glorioso JC, Yoshimura N. 271: Herpes Simplex Virus Vector-Mediated Delivery of Glial Cell Line-Derived Neurotrophic Factor Rescues Erectile Dysfunction of a Nerve-Sparing Radical Prostatectomy Model Journal of Urology. 177: 91-91. DOI: 10.1016/S0022-5347(18)30536-6  0.498
2006 Puskovic V, Wolfe D, Wechuck J, Krisky D, Collins J, Glorioso JC, Fink DJ, Mata M. HSV-mediated delivery of erythropoietin restores dopaminergic function in MPTP-treated mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. 14: 710-5. PMID 16949343 DOI: 10.1016/J.Ymthe.2006.07.004  0.402
2006 Jiang C, Ataai M, Ozuer A, Krisky D, Wechuck J, Pornsuwan S, Pourarian F, Glorioso JC. Inactivation of herpes simplex type 1 gene vector on immobilized metal affinity chromatography: oxidative damage by hydroxyl free radicals and its prevention. Biotechnology and Bioengineering. 95: 48-57. PMID 16673413 DOI: 10.1002/Bit.20943  0.714
2006 Sunyog AM, Wolfe D, Wechuck J, Krisky D, Jiang Y, Glorioso J. 355. A Platform for Gene Delivery to Embryonic Stem Cells Using HSV Molecular Therapy. 13: S135. DOI: 10.1016/J.Ymthe.2006.08.413  0.421
2006 Goins WF, Frampton AR, Nakao A, Tomiyama K, Clawson DS, Wechuck J, Huang S, Krisky DM, Cohen JB, Murase N, Glorioso JC. 235. Herpes Simplex Virus Vector Mediated Heme Oxygenase Gene Therapy of Heart Ischemia_Reperfusion Molecular Therapy. 13: S90. DOI: 10.1016/J.Ymthe.2006.08.261  0.3
2006 Srinivasan R, Sculptoreanu A, Wolfe D, Wechuck J, Watkins S, de Groat WC, Glorioso JC. 1071. Development and Characterization of HSV-1 Vector-Expressed Dominant Negative PKC epsilon for Pain Therapy Molecular Therapy. 13: S411. DOI: 10.1016/J.Ymthe.2006.08.1170  0.408
2005 Sunyog AM, Wolfe DP, Krisky D, Wechuck J, Jiang Y, Glorioso JC. 760. Development of an HSV-Based Model System to Identify Factors Acting in Embryonic Myogenesis Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.301  0.391
2005 Krisky DM, Wechuck J, Wolfe D, Huang S, Ozuer A, Glorioso JC. 757. Replication Defective HSV-1 Immediate Early (IE) Gene Mutants: A Comparison of Vector Toxicity Versus Transgene Expression Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.298  0.791
2004 Jiang C, Wechuck JB, Goins WF, Krisky DM, Wolfe D, Ataai MM, Glorioso JC. Immobilized cobalt affinity chromatography provides a novel, efficient method for herpes simplex virus type 1 gene vector purification. Journal of Virology. 78: 8994-9006. PMID 15308696 DOI: 10.1128/Jvi.78.17.8994-9006.2004  0.795
2004 Wolfe D, Wechuck JB, Krisky DM, Goff JP, Goins WF, Ozuer A, Epperly ME, Greenberger JS, Fink DJ, Glorioso JC. Delivery of herpes simplex virus-based vectors to stem cells. Methods in Molecular Biology (Clifton, N.J.). 246: 339-52. PMID 14970603 DOI: 10.1385/1-59259-650-9:339  0.803
2004 Jiang C, Wechuck JB, Goins WF, Krisky DM, Wolfe DP, Ataai MM, Glorioso JC. 794. Immobilized Cobalt Affinity Chromatography Provides a Novel, Efficient Method for HSV Gene Vector Purification Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.833  0.801
2002 Wechuck JB, Ozuer A, Goins WF, Wolfe D, Oligino T, Glorioso JC, Ataai MM. Effect of temperature, medium composition, and cell passage on production of herpes-based viral vectors. Biotechnology and Bioengineering. 79: 112-9. PMID 17590937 DOI: 10.1002/Bit.10310  0.749
2002 Ozuer A, Wechuck JB, Russell B, Wolfe D, Goins WF, Glorioso JC, Ataai MM. Evaluation of infection parameters in the production of replication-defective HSV-1 viral vectors. Biotechnology Progress. 18: 476-82. PMID 12052062 DOI: 10.1021/Bp010176K  0.777
2002 Ozuer A, Wechuck JB, Goins WF, Wolfe D, Glorioso JC, Ataai MM. Effect of genetic background and culture conditions on the production of herpesvirus-based gene therapy vectors. Biotechnology and Bioengineering. 77: 685-92. PMID 11807764 DOI: 10.1002/Bit.10162  0.78
2001 Burton EA, Wechuck JB, Wendell SK, Goins WF, Fink DJ, Glorioso JC. Multiple applications for replication-defective herpes simplex virus vectors. Stem Cells (Dayton, Ohio). 19: 358-77. PMID 11553845 DOI: 10.1634/Stemcells.19-5-358  0.661
2000 Wechuck JB, Goins WF, Glorioso JC, Ataai MM. Effect of protease inhibitors on yield of HSV-1-based viral vectors. Biotechnology Progress. 16: 493-6. PMID 10835254 DOI: 10.1021/Bp000016T  0.768
Show low-probability matches.